LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$4.58
+0.41 (+9.83%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+477.1% upside
Low Target
$20.55
Average Target
$26.43
High Target
$40.48
Current Price
$4.58
Current
$4.58
$4.58
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Scenario Analysis
Bear Case
$20.55
348.7%
Low target
Base Case
$26.43
+477.1%
Avg target
Bull Case
$40.48
+783.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$21.60
-78.8% from high
52-Week Low
$2.43
+88.5% from low
Target vs 52W High
$26.43
+22.4% vs high
Next Earnings Report
Nov 26, 2026 · After Market Close
19d
until earnings
EPS Est: $-0.92
Peer Consensus — Pharmaceuticals